GENB
Generate Biomedicines, Inc. Common Stock
NASDAQ: GENB · HEALTHCARE · BIOTECHNOLOGY
$12.63
+2.02% today
Updated 2026-04-30
Market cap
$1.59B
P/E ratio
—
P/S ratio
49.75x
EPS (TTM)
$-2.18
Dividend yield
—
52W range
$11 – $16
Volume
0.6M
Generate Biomedicines, Inc. Common Stock (GENB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |